Sign in

CIK 0001812364 · Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$120,165,474
in 11 filings, $3.7M under 10b5-1 plans

Net −$120,165,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. SVF Pauling (Cayman) Ltd −$116.4M 10% owner sold 22% of stake
  2. Patel Sanjiv −$2.8M President and CEO sold 23% of stake
  3. Catinazzo Thomas −$692K Chief Financial Officer sold 26% of stake
  4. Bergstrom Donald A −$204K President, R&D sold 3% of stake
  5. Rahmer Peter −$104K See remarks sold 2% of stake

Reading 98 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-30 Adams Brian Chief Legal Officer Sale −864 $21.56 $19K 136,092
2023-01-19 Patel Sanjiv President and CEO Option exercise +28,000 $5.04 $141K 282,554
2023-01-19 Patel Sanjiv President and CEO Sale −28,000 $20.02 $561K 254,554
2023-01-19 Patel Sanjiv President and CEO Option exercise · Stock Option (Right to Buy) −28,000 610,779
2023-01-18 Patel Sanjiv President and CEO Option exercise +28,000 $5.04 $141K 282,554
2023-01-18 Patel Sanjiv President and CEO Sale −28,000 $20.87 $584K 254,554
2023-01-18 Patel Sanjiv President and CEO Option exercise · Stock Option (Right to Buy) −28,000 638,779
2023-01-17 Rahmer Peter See remarks Grant or award +97,630 159,280
2023-01-17 Rahmer Peter See remarks Grant or award · Stock Option (Right to Buy) +97,630 97,630
2023-01-17 Rahmer Peter See remarks Grant or award · Stock Option (Right to Buy) +97,630 97,630
2023-01-17 Patel Sanjiv President and CEO Option exercise +28,000 $5.04 $141K 282,554
2023-01-17 Patel Sanjiv President and CEO Sale −28,000 $20.23 $566K 254,554
2023-01-17 Patel Sanjiv President and CEO Option exercise · Stock Option (Right to Buy) −28,000 666,779
2023-01-17 Patel Sanjiv President and CEO Grant or award · Stock Option (Right to Buy) +701,680 701,680
2023-01-17 Patel Sanjiv President and CEO Grant or award · Stock Option (Right to Buy) +701,680 701,680
2023-01-17 Catinazzo Thomas Chief Financial Officer Grant or award +101,115 151,346
2023-01-17 Catinazzo Thomas Chief Financial Officer Grant or award · Stock Option (Right to Buy) +104,600 104,600
2023-01-17 Catinazzo Thomas Chief Financial Officer Grant or award · Stock Option (Right to Buy) +97,630 97,630
2023-01-17 Adams Brian Chief Legal Officer Grant or award +85,425 136,956
2023-01-17 Adams Brian Chief Legal Officer Grant or award · Stock Option (Right to Buy) +97,630 97,630

Page 14 of 17 · 329 trades